Dietary and supplemental long chain omega-3 polyunsaturated fatty acids (n-3 PUFA) have shown vascular benefits for the general population, but effects among people with chronic kidney disease (CKD) are largely uncertain. We aimed to evaluate the effects of n-3 PUFA intake among patients with CKD
The prevalence rate of chronic kidney disease (CKD) is increasing worldwide, and cardiovascular dise...
Chronic kidney disease (CKD) is a major public health problem and can result in end-stage renal d...
Purpose: The prevalence of chronic kidney disease (CKD) is increasing rapidly in many countries and ...
Dietary and supplemental long chain omega-3 polyunsaturated fatty acids (n-3 PUFA) have shown vascul...
Background & aims: Dietary and supplemental long chain omega-3 polyunsaturated fatty acids (n-3 PUFA...
Background & aims: Dietary and supplemental long chain omega-3 polyunsaturated fatty acids (n-3 PUFA...
Background & aims: Dietary and supplemental long chain omega-3 polyunsaturated fatty acids (n-3 PUFA...
The aim of this study was to evaluate the benefits and risks of omega-3 fatty acid supplementation i...
Epidemiological studies show that circulating polyunsaturated fatty acids contribute to preserve ren...
Polyunsaturated fatty acid (PUFA) intake is generally associated with better renal function, while t...
Chronic kidney disease (CKD) is an increasingly common public health problem that increases the risk...
In general, patients with end-stage renal disease treated with chronic hemodialysis have plasma and ...
After more than 25 years of published investigation, including randomized controlled trials, the rol...
After more than 25 years of published investigation, including randomized controlled trials, the rol...
OBJECTIVE: To assess the prospective associations of circulating levels of omega 3 polyunsaturated f...
The prevalence rate of chronic kidney disease (CKD) is increasing worldwide, and cardiovascular dise...
Chronic kidney disease (CKD) is a major public health problem and can result in end-stage renal d...
Purpose: The prevalence of chronic kidney disease (CKD) is increasing rapidly in many countries and ...
Dietary and supplemental long chain omega-3 polyunsaturated fatty acids (n-3 PUFA) have shown vascul...
Background & aims: Dietary and supplemental long chain omega-3 polyunsaturated fatty acids (n-3 PUFA...
Background & aims: Dietary and supplemental long chain omega-3 polyunsaturated fatty acids (n-3 PUFA...
Background & aims: Dietary and supplemental long chain omega-3 polyunsaturated fatty acids (n-3 PUFA...
The aim of this study was to evaluate the benefits and risks of omega-3 fatty acid supplementation i...
Epidemiological studies show that circulating polyunsaturated fatty acids contribute to preserve ren...
Polyunsaturated fatty acid (PUFA) intake is generally associated with better renal function, while t...
Chronic kidney disease (CKD) is an increasingly common public health problem that increases the risk...
In general, patients with end-stage renal disease treated with chronic hemodialysis have plasma and ...
After more than 25 years of published investigation, including randomized controlled trials, the rol...
After more than 25 years of published investigation, including randomized controlled trials, the rol...
OBJECTIVE: To assess the prospective associations of circulating levels of omega 3 polyunsaturated f...
The prevalence rate of chronic kidney disease (CKD) is increasing worldwide, and cardiovascular dise...
Chronic kidney disease (CKD) is a major public health problem and can result in end-stage renal d...
Purpose: The prevalence of chronic kidney disease (CKD) is increasing rapidly in many countries and ...